Key result
Amiodarone effectively treats ventricular arrhythmias but remains significantly limited by drug toxicity.
Why the study?
Ventricular arrhythmias remain a major cause of morbidity and mortality, but while amiodarone is widely used for efficacy and low pro-arrhythmogenic effect, toxicity presents a significant clinical limitation.
This review provides a comprehensive overview of the pharmacology, clinical indications, dosage, and toxicity of amiodarone for the management of ventricular arrhythmias in contemporary clinical practice.
No takes yet. Share an insight, caveat, or question.
Toxicity limits amiodarone for ventricular arrhythmias despite efficacy; leaves open safer alternatives for prospective trials.
Pannone et al. (2021) conducted a review in Ventricular arrhythmias. Amiodarone was evaluated. Amiodarone remains a widely used and effective treatment for ventricular arrhythmias across various clinical settings, though its application is significantly limited by drug toxicity.